Stock Events

Biomind Labs 

C$0.14
2
+C$0.01+8% Thursday 20:14

Statistics

Day High
0.14
Day Low
0.14
52W High
1.21
52W Low
0.03
Volume
500
Avg. Volume
949
Mkt Cap
89.71M
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BMND.NEO. It's not an investment recommendation.

About

Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; and BMND08, a 5-Methoxy-N,N-dimethyltryptamine based candidate that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment. It is also developing new and preclinical drug candidates, including BMND02 for treating fibromyalgia, BMND03 for treating addictive disorders, BMND05 for treating chronic pain, BMND06 for treating inflammation, and BMND07 for treating major depressive disorder. The company is headquartered in Canelones, Uruguay.
Show more...
CEO
Mr. Alejandro Antalich
Employees
9
Country
CA
ISIN
CA0907021012
WKN
000A3CSQR

Listings